Company intelligence / Profile preview

Therapy X Clinic

Buffalo, New York, United Statesfacebook.com ↗

Ownership: Private
Development stage: Other

Overview

TherapyX Inc. develops innovative microparticulate immune therapeutics designed for parenteral, oral, and mucosal delivery to treat cancer (notably pancreatic), infectious diseases such as gonorrhea, and inflammatory disorders. The company has partnered with leading academic institutions to advance its pipeline but has not yet reported clinical trial outcomes.

Therapeutic areas: Infectious DiseasesImmunologyOncology
Modalities: ProteinBiologic
Industry: Biotech

Partnerships

University of RochesterIntravacc

Beyond the preview

Go deeper on Therapy X Clinic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therapy X Clinic.

Explore the full profile